Bank of New Hampshire’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.53K Sell
200
-951
-83% -$42.5K ﹤0.01% 470
2026
Q1
$55.5K Buy
1,151
+951
+476% +$44.3K 0.01% 309
2025
Q4
$9.69K Hold
200
﹤0.01% 409
2025
Q3
$9.44K Hold
200
﹤0.01% 413
2025
Q2
$9.66K Buy
+200
New +$10.2K ﹤0.01% 411
2023
Q2
Sell
-57
Closed -$3.1K 515
2023
Q1
$3.1K Hold
57
﹤0.01% 469
2022
Q4
$3K Hold
57
﹤0.01% 482
2022
Q3
$2K Hold
57
﹤0.01% 501
2022
Q2
$3K Hold
57
﹤0.01% 497
2022
Q1
$3K Buy
+57
New +$2.94K ﹤0.01% 500

Other funds holding SNY

Bank of New Hampshire's SNY Position: Q2 2026 in Review

Bank of New Hampshire reduced its Sanofi (SNY) stake by 83% in Q2 2026, selling an estimated $42.5K and leaving 200 shares worth $8.53K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

Bank of New Hampshire first reported a position in SNY in Q1 2022 and has held it in 10 quarters since. The position peaked at $55.5K in Q1 2026. 440 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Bank of New Hampshire held 200 shares of Sanofi worth $8.53K as of Q2 2026.
  • Bank of New Hampshire sold 951 Sanofi shares in Q2 2026, an estimated $42.5K.
  • Sanofi made up ﹤0.01% of Bank of New Hampshire's portfolio in Q2 2026, its #470 holding.
  • Bank of New Hampshire first reported a position in Sanofi in Q1 2022 and has held it in 10 quarters since.
  • Bank of New Hampshire's Sanofi position peaked at $55.5K in Q1 2026.
  • 440 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.